1. Home
  2. WK vs AMRX Comparison

WK vs AMRX Comparison

Compare WK & AMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Workiva Inc.

WK

Workiva Inc.

HOLD

Current Price

$51.32

Market Cap

3.2B

Sector

Technology

ML Signal

HOLD

Logo Amneal Pharmaceuticals Inc.

AMRX

Amneal Pharmaceuticals Inc.

HOLD

Current Price

$13.64

Market Cap

3.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WK
AMRX
Founded
2008
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
3.7B
IPO Year
2014
2018

Fundamental Metrics

Financial Performance
Metric
WK
AMRX
Price
$51.32
$13.64
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
10
5
Target Price
$95.30
$15.60
AVG Volume (30 Days)
986.1K
1.4M
Earning Date
05-05-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
52.53
157.89
EPS
0.33
0.22
Revenue
$884,568,000.00
N/A
Revenue This Year
$20.85
$4.48
Revenue Next Year
$15.43
$7.13
P/E Ratio
N/A
$61.07
Revenue Growth
19.75
N/A
52 Week Low
$50.98
$7.02
52 Week High
$97.10
$15.42

Technical Indicators

Market Signals
Indicator
WK
AMRX
Relative Strength Index (RSI) 36.25 63.04
Support Level N/A $12.45
Resistance Level $64.76 $15.21
Average True Range (ATR) 2.37 0.50
MACD 0.12 0.08
Stochastic Oscillator 21.18 82.54

Price Performance

Historical Comparison
WK
AMRX

About WK Workiva Inc.

Workiva Inc is an AI-powered platform for trust, transparency, and accountability. Accounting, finance, sustainability, risk, and audit teams rely on Workiva for their mission-critical work. It transforms how customers connect data, unify processes, and empower teams in a secure, AI-powered, audit-ready, collaborative platform. Company's Geographical region consist of USA, Netherland, UK, and Others. Majority of revenue is from USA.

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE. It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment, which derives maximum revenue, focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

Share on Social Networks: